OS Therapies (OSTX) Other Non Operating Income (2024 - 2026)

OS Therapies (OSTX) has 3 years of Other Non Operating Income data on file, last reported at -$75344.0 in Q1 2026.

• Quarterly Other Non Operating Income fell 114257.58% year-over-year to -$75344.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$75149.0 (changed N/A YoY) and the FY2024 annual result came in at $33997.0, changed N/A from the prior year.
• Other Non Operating Income eased to -$75344.0 in Q1 2026, from $65.0 in the prior quarter.
• In the past five years, Other Non Operating Income ranged from a high of $33996.0 in Q4 2024 to a low of -$75344.0 in Q1 2026.
• A 3-year average of -$8230.6 and a median of $65.0 in 2025 frame the typical range for Other Non Operating Income.
• The widest YoY moves for Other Non Operating Income: up 114257.58% in 2026, down 114257.58% in 2026.
• Tracing OSTX's Other Non Operating Income over 3 years: stood at $33996.0 in 2024, then tumbled by 99.81% to $65.0 in 2025, then plunged by 116013.85% to -$75344.0 in 2026.
• The last three Other Non Operating Income figures came in at -$75344.0 (Q1 2026), $65.0 (Q3 2025), and $64.0 (Q2 2025), per Business Quant data.